Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
kras g12d inhibitor amgen | 0.63 | 0.8 | 6994 | 43 | 25 |
kras | 1.83 | 0.7 | 9103 | 6 | 4 |
g12d | 1.12 | 0.5 | 1266 | 12 | 4 |
inhibitor | 1.94 | 0.8 | 7746 | 43 | 9 |
amgen | 0.38 | 0.1 | 6567 | 18 | 5 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
kras g12d inhibitor amgen | 0.7 | 0.8 | 8108 | 90 |
kras g12d inhibitor clinical trial | 0.6 | 0.5 | 394 | 38 |
kras g12c inhibitor 1 | 0.5 | 0.1 | 7592 | 47 |
kras g12c on inhibitor | 0.22 | 0.5 | 3884 | 27 |
kras g12c inhibitor drugs | 1.27 | 0.5 | 8314 | 79 |
kras g12c inhibitor adagrasib | 0.96 | 0.8 | 3331 | 58 |
kras g12c inhibitor-12 | 0.53 | 0.1 | 4910 | 79 |
kras g12c inhibitor resistance | 1.86 | 0.2 | 9797 | 98 |
amgen kras g12c fda approval | 1.89 | 0.3 | 3514 | 28 |
kras g12c inhibitor fda approval | 0.48 | 1 | 3683 | 100 |
fda approved kras g12c inhibitor | 0.52 | 0.3 | 7416 | 18 |
kras g12d inhibitor mirati | 0.36 | 0.2 | 9294 | 14 |
ct26 kras g12d inhibitor | 0.8 | 0.3 | 8177 | 69 |
kras g12d mutation and treatment | 1.95 | 0.3 | 6244 | 50 |
kras g12d recombinant protein | 1.24 | 0.3 | 9462 | 36 |
kras g12c inhibitor clinical trial | 0.14 | 0.1 | 5800 | 68 |
kras g12c inhibitor-12_1855 | 0.46 | 0.5 | 9850 | 53 |
the clinical kras g12c inhibitor amg 510 | 0.26 | 0.8 | 9410 | 52 |
kras g12d/+ | 0.31 | 0.2 | 8211 | 62 |
kras g12c covalent inhibitor | 0.13 | 0.1 | 475 | 49 |